0001104659-23-078152.txt : 20230705
0001104659-23-078152.hdr.sgml : 20230705
20230705163221
ACCESSION NUMBER: 0001104659-23-078152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carter Todd Alfred
CENTRAL INDEX KEY: 0001944011
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37625
FILM NUMBER: 231069666
MAIL ADDRESS:
STREET 1: C/O VOYAGER THERAPEUTICS, INC.
STREET 2: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Voyager Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640266
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-5340
MAIL ADDRESS:
STREET 1: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
tm2320623-1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-30
0
0001640266
Voyager Therapeutics, Inc.
VYGR
0001944011
Carter Todd Alfred
C/O VOYAGER THERAPEUTICS, INC.
64 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Scientific Officer
1
Common Stock
2023-06-30
4
M
0
5000
2.85
A
70360
D
Common Stock
2023-06-30
4
S
0
5000
11.41
D
65360
D
Stock Option (Right to Buy)
2.85
2023-06-30
4
M
0
5000
0
D
2032-01-13
Common Stock
5000
45000
D
The reported sale of 5,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.
This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. The vesting commencement date of the option is the grant date, January 13, 2022. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
/s/ Scott MacDonald, as Attorney-in-Fact for Todd Carter
2023-07-05